a16z Joint Creation: It is unreasonable to be bearish on AI investment portfolio under the background of continuous progress in open source AI
Shaw, the co-founder of ai16z, posted on social media platform X stating that it is unreasonable to be pessimistic about the AI investment portfolio against the backdrop of continuous improvement and cost reduction in open-source AI technology.
He emphasized that advancements in open-source AI technology can allow all AI products and intelligent agents to improve their performance levels for free. This technological dividend will continue to drive the development of the entire AI industry.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like


BTC market cap briefly dropped out of the top 15 global assets

From $617 to $350: CVS Sets "Break-Even Price" for Weight-Loss Drugs, Says Pharmaceutical Companies Can Still Profit
An analysis of insurance claims data found that if GLP-1 drugs used for weight loss and diabetes are priced below $350 per month, payers—such as employers and plan sponsors—would achieve net savings due to a decrease in related healthcare service utilization.
